February 26, 2026 Financial Statements for Q4 2025 (Audited)
February 26, 2026 Management Discussion and Analysis for Q4 2025 (Audited)
November 11, 2025 Financial Statements for Q3 2025 (Reviewed)
November 11, 2025 Management Discussion and Analysis for Q3 2025 (Reviewed)
August 28, 2025 Financial Statements for Q2 2025 (Audited)
August 28, 2025 Management Discussion and Analysis for Q2 2025 (Audited)
May 15, 2025 Financial Statements for Q1 2025 (Reviewed)
May 15, 2025 Management Discussion and Analysis for Q1 2025 (Reviewed)
January 20, 2026Financial Statements for Q4 2025 (Unaudited)
January 20, 2026Financial Results for Q4 2025 (Unaudited)
October 21, 2025Financial Statements for Q3 2025 (Unreviewed)
October 21, 2025Financial Results for Q3 2025 (Unreviewed)
July 17, 2025Financial Statements for Q2 2025 (Unaudited)
July 17, 2025Financial Results for Q2 2025 (Unaudited)
January 20, 2026Summary Statement of Assets and Liabilities (C.B. 1.1) for December 2025
December 19, 2025Summary Statement of Assets and Liabilities (C.B. 1.1) for November 2025
November 21, 2025Summary Statement of Assets and Liabilities (C.B. 1.1) for October 2025
October 21, 2025Summary Statement of Assets and Liabilities (C.B. 1.1) for September 2025
September 19, 2025Summary Statement of Assets and Liabilities (C.B. 1.1) for August 2025
August 21, 2025Summary Statement of Assets and Liabilities (C.B. 1.1) for July 2025
July 17, 2025Summary Statement of Assets and Liabilities (C.B. 1.1) for June 2025
June 20, 2025Summary Statement of Assets and Liabilities (C.B. 1.1) for May 2025
May 21, 2025Summary Statement of Assets and Liabilities (C.B. 1.1) for April 2025
April 17, 2025Summary Statement of Assets and Liabilities (C.B. 1.1) for March 2025
March 21, 2025Summary Statement of Assets and Liabilities (C.B. 1.1) for February 2025
February 21, 2025Summary Statement of Assets and Liabilities (C.B. 1.1) for January 2025
April 25, 2025 Minutes of the 32nd Annual Ordinary Meeting of Shareholders
April 11, 2025 Resolutions of the 32nd Annual Ordinary Meeting of Shareholders
March 7, 2025Invitation Letter for 32nd Annual Ordinary Meeting of Shareholders
March 7, 2025Summary of the Financial Information from the Form 56-1 One Report 2024
March 7, 2025Appointment of Proxy Holder for 32nd Annual Ordinary Meeting of Shareholders
March 7, 2025Notification of Meeting
March 7, 2025Documents required to register for the meeting
March 7, 2025Instructions for booking seats for the 2025 Annual Ordinary Meeting of Shareholders
February 20, 2025 Financial Statements for Q4 2024 (Audited)
February 20, 2025 Management Discussion and Analysis for Q4 2024 (Audited)
November 14, 2024 Financial Statements for Q3 2024 (Reviewed)
November 14, 2024 Management Discussion and Analysis for Q3 2024 (Reviewed)
August 22, 2024 Financial Statements for Q2 2024 (Audited)
August 22, 2024 Management Discussion and Analysis for Q2 2024 (Audited)
May 14, 2024 Financial Statements for Q1 2024 (Reviewed)
May 14, 2024 Management Discussion and Analysis for Q1 2024 (Reviewed)
January 21, 2025 Financial Statements for Q4 2024 (Unaudited)
January 21, 2025 Financial Results for Q4 2024 (Unaudited)
October 17, 2024 Financial Statements for Q3 2024 (Unreviewed)
October 17, 2024 Financial Results for Q3 2024 (Unreviewed)
July 18, 2024 Financial Statements for Q2 2024 (Unaudited)
July 18, 2024 Financial Results for Q2 2024 (Unaudited)
April 18, 2024 Financial Statements for Q1 2024 (Unreviewed)
January 21, 2025Summary Statement of Assets and Liabilities (C.B. 1.1) for December 2024
December 20, 2024Summary Statement of Assets and Liabilities (C.B. 1.1) for November 2024
November 21, 2024Summary Statement of Assets and Liabilities (C.B. 1.1) for October 2024
October 17, 2024Summary Statement of Assets and Liabilities (C.B. 1.1) for September 2024
September 20, 2024Summary Statement of Assets and Liabilities (C.B. 1.1) for August 2024
August 21, 2024Summary Statement of Assets and Liabilities (C.B. 1.1) for July 2024
July 18, 2024Summary Statement of Assets and Liabilities (C.B. 1.1) for June 2024
June 21, 2024Summary Statement of Assets and Liabilities (C.B. 1.1) for May 2024
May 21, 2024Summary Statement of Assets and Liabilities (C.B. 1.1) for April 2024
April 18, 2024Summary Statement of Assets and Liabilities (C.B. 1.1) for March 2024
March 21, 2024Summary Statement of Assets and Liabilities (C.B. 1.1) for February 2024
February 21, 2024Summary Statement of Assets and Liabilities (C.B. 1.1) for January 2024
April 25, 2024Minutes of the 31st Annual Ordinary Meeting of Shareholders
April 11, 2024Resolutions of the 31st Annual Ordinary Meeting of Shareholders
March 8, 2024Invitation Letter for 31st Annual Ordinary Meeting of Shareholders
March 8, 2024Summary of the Financial Information from the Form 56-1 One Report 2023
March 8, 2024Appointment of Proxy Holder for 31st Annual Ordinary Meeting of Shareholders
March 8, 2024Notification of Meeting
March 8, 2024Documents required to register for the meeting
March 8, 2024Instructions for booking seats for the 2024 Annual Ordinary Meeting of Shareholders
February 22, 2024 Financial Statements for Q4 2023 (Audited)
February 22, 2024 Management Discussion and Analysis for Q4 2023 (Audited)
November 14, 2023 Financial Statements for Q3 2023 (Reviewed)
November 14, 2023 Management Discussion and Analysis for Q3 2023 (Reviewed)
August 24, 2023 Financial Statements for Q2 2023 (Audited)
August 24, 2023 Management Discussion and Analysis for Q2 2023 (Audited)
May 11, 2023 Financial Statements for Q1 2023 (Reviewed)
May 11, 2023 Management Discussion and Analysis for Q1 2023 (Reviewed)
January 18, 2024Financial Statements for Q4 2023 (Unaudited)
January 18, 2024Financial Results for Q4 2023 (Unaudited)
October 19,2023Financial Statements for Q3 2023 (Unreviewed)
October 19,2023Financial Results for Q3 2023 (Unreviewed)
July 20,2023Financial Statements for Q2 2023 (Unaudited)
July 20,2023Financial Results for Q2 2023 (Unaudited)
January 18, 2024Summary Statement of Assets and Liabilities (C.B. 1.1) for December 2023
December 21, 2023Summary Statement of Assets and Liabilities (C.B. 1.1) for November 2023
November 21, 2023Summary Statement of Assets and Liabilities (C.B. 1.1) for October 2023
October 19, 2023Summary Statement of Assets and Liabilities (C.B. 1.1) for September 2023
September 21, 2023Summary Statement of Assets and Liabilities (C.B. 1.1) for August 2023
August 21, 2023Summary Statement of Assets and Liabilities (C.B. 1.1) for July 2023
July 20, 2023Summary Statement of Assets and Liabilities (C.B. 1.1) for June 2023
June 21, 2023Summary Statement of Assets and Liabilities (C.B. 1.1) for May 2023
May 22, 2023Summary Statement of Assets and Liabilities (C.B. 1.1) for April 2023
April 20, 2023Summary Statement of Assets and Liabilities (C.B. 1.1) for March 2023
March 21, 2023Summary Statement of Assets and Liabilities (C.B. 1.1) for February 2023
February 21, 2023Summary Statement of Assets and Liabilities (C.B. 1.1) for January 2023
April 26, 2023Minutes of the 30th Annual Ordinary Meeting of Shareholders
April 12, 2023Resolutions of the 30th Annual Ordinary Meeting of Shareholders
March 9, 2023Invitation Letter for 30th Annual Ordinary Meeting of Shareholders
March 9, 2023Summary of the Financial Information from the Form 56-1 One Report 2022
March 9, 2023 Appointment of Proxy Holder for 30th Annual Ordinary Meeting of Shareholders
March 9, 2023Notification of Meeting
March 9, 2023Documents required to register for the meeting
March 9, 2023Instructions for booking seats for the 2023 Annual Ordinary Meeting of Shareholders
February 23, 2023Financial Statements for Q4 2022 (Audited)
February 23, 2023Management Discussion and Analysis for Q4 2022 (Audited)
November 10, 2022Financial Statements for Q3 2022 (Reviewed)
November 10, 2022Management Discussion and Analysis for Q3 2022 (Reviewed)
August 25, 2022Financial Statements for Q2 2022 (Audited)
August 25, 2022Management Discussion and Analysis for Q2 2022 (Audited)
May 12, 2022Financial Statements for Q1 2022 (Reviewed)
May 12, 2022Management Discussion and Analysis for Q1 2022 (Reviewed)
January 19, 2023Financial Statements for Q4 2022 (Unaudited)
January 19, 2023Financial Results for Q4 2022 (Unaudited)
October 20, 2022Financial Statements for Q3 2022 (Unreviewed)
October 20, 2022Financial Results for Q3 2022 (Unreviewed)
July 21, 2022Financial Statements for Q2 2022 (Unaudited)
July 21, 2022Financial Results for Q2 2022 (Unaudited)
January 19, 2023Summary Statement of Assets and Liabilities (C.B. 1.1) for December 2022
December 21, 2022Summary Statement of Assets and Liabilities (C.B. 1.1) for November 2022
November 21, 2022Summary Statement of Assets and Liabilities (C.B. 1.1) for October 2022
October 20, 2022Summary Statement of Assets and Liabilities (C.B. 1.1) for September 2022
September 21, 2022Summary Statement of Assets and Liabilities (C.B. 1.1) for August 2022
August 22, 2022Summary Statement of Assets and Liabilities (C.B. 1.1) for July 2022
July 21, 2022Summary Statement of Assets and Liabilities (C.B. 1.1) for June 2022
June 21, 2022Summary Statement of Assets and Liabilities (C.B. 1.1) for May 2022
May 20, 2022Summary Statement of Assets and Liabilities (C.B. 1.1) for April 2022
April 21, 2022Summary Statement of Assets and Liabilities (C.B. 1.1) for March 2022
March 21, 2022Summary Statement of Assets and Liabilities (C.B. 1.1) for February 2022
February 21, 2022Summary Statement of Assets and Liabilities (C.B. 1.1) for January 2022
May 13, 2022Minutes of the 29th Annual Ordinary Meeting of Shareholders
April 12, 2022Resolutions of the 29th Annual Ordinary Meeting of Shareholders
March 10, 2022Invitation Letter for 29th Annual Ordinary Meeting of Shareholders
March 10, 2022Summary of the Financial Information from the Form 56-1 One Report 2021
March 10, 2022Appointment of Proxy Holder for 29th Annual Ordinary Meeting of Shareholders
March 10, 2022Notification of Meeting
March 10, 2022Documents required to register for the meeting
March 10, 2022Measures and guidelines on prevention of the spread of the Covid-19
March 10, 2022Instructions for booking seats for the 29th Annual Ordinary Meeting of Shareholders
March 10, 2022FAQs for the 29th Annual Ordinary Meeting of Shareholders
